| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Michael J. Ambrogi last filed a Form 4 in July 2020, as Chief Operating Officer at NVCR. Michael J. Ambrogi's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 220,867 shares of NVCR. The NVCR filings lean toward selling, a net 1,043,396 shares.
Michael J. Ambrogi has 42 Form 4 filings on record from December 2016 to July 2020, all as Chief Operating Officer at NovoCure (NVCR), 2016–2020.
The 126 reported transactions were 73 open-market sales, 37 option exercises, 8 option or other derivative awards and 4 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 30 sales worth about $44.1M.
The largest open-market sale was 110,868 shares of NVCR at an average $60.00 on June 19, 2019, about $6.7M.
Shares as reported in the last Form 4 for each company; the most recent is from July 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2020 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 46,293 | $66.88 | $3,096,038.24 | -17.3% | |
| Apr 14, 2020 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 58,500 | $70.11 | $4,101,564.20 | -20.9% | |
| Mar 6, 2020 | NVCR Novocure Ltd | Chief Operating Officer | Sell | 2,274 | $69.53 | $158,120.32 | -1.0% | |
| Feb 28, 2020 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 2,673 | $72.22 | $193,030.70 | -1.3% | |
| Feb 25, 2020 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 11,647 | $81.16 | $945,223.93 | -5.4% | |
| Nov 4, 2019 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 80,819 | $79.00 | $6,384,701.00 | -30.3% | |
| Jun 19, 2019 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 110,868 | $60.00 | $6,652,080.00 | -37.4% | |
| Jun 6, 2019 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 5,999 | $54.79 | $328,661.21 | -3.1% | |
| Jun 5, 2019 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 17,500 | $54.14 | $947,485.00 | -8.6% | |
| Jun 4, 2019 | NVCR Novocure Ltd | Chief Operating Officer | Sale+OE | 35,000 | $52.62 | $1,841,741.10 | -15.9% |